DermaSensor

Miami, FL · Founded 2009 · Privately Held (backing)

Developer of a skin cancer evaluation technology designed to provide spectroscopy and machine learning technologies to detect skin cancer early. DermaSensor is based in Miami, FL and was founded in 2009. It was valued at $66.8 million at its later-stage round in Dec 2024, the last priced event on record. It has raised $66.7 million across 2 recorded rounds; the latest was an $8.9 million early-stage round in Nov 2024.

PMV mark · valuation
$66.8M
Oct 2026
Priced at
its later-stage round
Dec 2024
Total raised
$66.7M
Last round
Early Stage VC
Nov 2024
What is DermaSensor worth?
$66.8MPrivateMarketView mark · Oct 2026

Valued at $66.8M at its later-stage round, Dec 2024. Nothing has traded since.

Free account
More of DermaSensor with a free account
  • ·The complete investor list: 19 names
  • ·Watch DermaSensor: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

DermaSensor funding history

2 rounds
DateRoundRaisedPost-money
Nov 2024Early Stage VC$8.9M▮
Feb 2020Early Stage VC$5.9M▮
Unlock post-money valuations

Membership and data by Private Market View

DermaSensor valuation

DermaSensor was valued at $66.8 million at its later-stage round in Dec 2024. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has DermaSensor raised?

DermaSensor has raised $66.7 million in total; 2 of its rounds are on record. The largest on record was an $8.9 million early-stage round in Nov 2024.

DermaSensor has filed 2 Form Ds with the SEC since 2020, most recently in Dec 2024 ($8.9 million sold to 41 investors).

Institutional holders and vehicles

In the last 12 months, 1 investment vehicle was formed to buy DermaSensor shares, reporting $55,000 sold to 4 investors, per SEC Form D filings (most recent Mar 2026).

How DermaSensor's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For DermaSensor, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about DermaSensor

What is DermaSensor worth?
DermaSensor is valued at $66.8M as of Oct 2026. Valued at $66.8M at its later-stage round, Dec 2024. Nothing has traded since.
How much has DermaSensor raised?
DermaSensor has raised $66.7M in total funding across 2 recorded rounds.
When did DermaSensor last raise?
DermaSensor last raised in Nov 2024 (Early Stage VC), raising $8.9M.